Hormonal IUD (Mirena/Kyleena) Patient Assistance for Low-Income Women: Every Real Option in 2026

Why the Sticker Price Is Not What Most Women Pay

The list price for a hormonal IUD sits near $1,000 before you add the insertion visit, but most women who want one do not pay anything close to that amount. The Affordable Care Act requires most private insurance plans and Medicaid to cover all FDA-approved contraceptive methods, including hormonal IUDs, with no cost sharing. ACOG supports IUD coverage as preventive care under that mandate.

Still, gaps exist. High-deductible plans, grandfathered employer plans, and plans with narrow formularies can leave women facing hundreds or thousands of dollars out of pocket. Women who are uninsured, underinsured, or undocumented often have no automatic pathway at all. That is exactly where the programs described below apply.

One more thing worth knowing up front: these programs change. Funding cycles end, income thresholds shift, and clinic availability fluctuates. Always call ahead to verify current eligibility before your appointment.

Understanding the Two Most Common Hormonal IUDs

Before comparing access routes, it helps to know what you are actually choosing between, because the two devices differ in ways that matter clinically.

Mirena (52 mg levonorgestrel, LNG-IUS)

Mirena releases approximately 20 mcg of levonorgestrel per day at first, declining over time. The FDA extended its approved duration to 8 years in 2022. At this dose, Mirena typically causes significant reduction in menstrual bleeding and is FDA-approved to treat heavy menstrual bleeding (HMB) in addition to providing contraception. This dual indication matters for insurance: if you have HMB or endometriosis-related bleeding, your prescriber can code the IUD for that indication and your plan may cover it even if contraceptive coverage is limited.

Kyleena (19.5 mg levonorgestrel)

Kyleena releases a lower dose, approximately 17.5 mcg per day initially, and is approved for 5 years of use. The smaller frame and lower hormone dose make it a common choice for women who have not been pregnant, adolescents, and women in perimenopause who want lighter hormone exposure. Kyleena does not carry an HMB indication, which means it has fewer dual-coding opportunities for insurance purposes.

Which One Is More Affordable Through Assistance Programs?

Both devices are manufactured by Bayer and both appear in Bayer's assistance programs. Cash price is comparable between the two. Over a full course of use, Mirena's longer approved duration (8 vs. 5 years) makes it slightly more cost-efficient per year if you plan to use it for the full period, but Kyleena may be the better clinical fit for your situation regardless of cost.

Medicaid: The Highest-Impact Option for Low-Income Women

If you qualify for Medicaid, you likely qualify for a fully covered hormonal IUD, including the device, the insertion visit, and follow-up.

ACA Contraceptive Mandate and Medicaid

All state Medicaid programs are required to cover contraceptive services, and the federal government matches a significant share of those costs. The ACA's preventive services mandate means there is no cost sharing for most contraceptive methods, including IUDs, under plans that fall within its scope.

For women below 133% of the federal poverty level (FPL), standard Medicaid covers the IUD at $0. For women between 133% and 200% FPL in expansion states, coverage is also typically available.

Postpartum IUD Insertion Under Medicaid

This is one of the most underused access pathways in existence. Immediate postpartum LARC insertion (within 10 minutes of placenta delivery or before hospital discharge) is covered by Medicaid in the majority of states when billed separately from the delivery bundle. If you are pregnant or just gave birth and planning your next contraceptive method, ask your OB or midwife about postpartum IUD placement before discharge. This eliminates the barrier of a separate device purchase and insertion visit.

Family Planning Medicaid Waivers

Many states operate Medicaid family planning waiver programs that extend coverage specifically for contraceptive services to women who do not otherwise qualify for full Medicaid. Income thresholds vary by state but can reach up to 200% or even 250% FPL. These programs typically do not require full Medicaid enrollment, cover only family planning services (not general medical care), and can be applied for quickly. Search "[your state] family planning Medicaid waiver" or ask your Title X clinic to screen you.

Title X Family Planning Clinics

Title X is the only federal grant program dedicated solely to family planning. Clinics funded under Title X are required to offer services on a sliding-fee scale based on income, and they must offer the full range of FDA-approved contraceptive methods, including IUDs.

What You Actually Pay

For women at or below 100% FPL, Title X guidelines mandate that services are provided free of charge. For women between 100% and 250% FPL, fees are scaled proportionally. A woman at 150% FPL might pay $50 to $200 for an IUD insertion that would otherwise cost $1,000 or more. Women above 250% FPL pay fees based on a published schedule, but Title X clinics still often charge less than private practices.

How to Find a Title X Clinic

The U.S. Department of Health and Human Services maintains a clinic locator at opa-fpclinicdb.com, though Planned Parenthood health centers and many community health centers operate under Title X funding and can be found through their own locators as well.

Call ahead and ask specifically: "Do you offer IUDs on a sliding-scale fee? Do you bill through Title X funding?" Not every location within a network has the same services.

Bayer's Patient Assistance Programs

Bayer, the manufacturer of both Mirena and Kyleena, operates patient assistance pathways directly. As of 2026, two primary routes exist, though eligibility criteria and program availability can change without advance notice.

Bayer US Patient Assistance Program (PAP)

Bayer's PAP provides Mirena and Kyleena at no cost to patients who meet income criteria and lack adequate insurance coverage. General eligibility guidelines historically require:

• U.S. Residency
• No private insurance coverage for the device
• Household income at or below 200% to 400% FPL (thresholds shift; verify directly)
• A valid prescription from a licensed provider

The application is typically submitted by your healthcare provider on your behalf. The device ships to the prescribing clinic, not to your home. Contact Bayer directly at 1-888-842-2937 or visit Bayer's US website to confirm current thresholds and application process.

The "Pay-Nothing" Framework for Hormonal IUD Access

To help you quickly identify which pathway applies to your situation, here is a structured decision sequence developed by the WomanRx clinical team:

1. Have Medicaid or a Medicaid waiver? Stop here. Your IUD should be $0. Ask your clinic to verify billing before the appointment.
2. Have private insurance with an ACA-compliant plan? File a coverage request for "levonorgestrel IUD" as a preventive service. If denied, appeal citing the contraceptive mandate.
3. Have a high-deductible or grandfathered plan? Apply directly to Bayer PAP. Your provider submits the application; you bring the prescription.
4. Uninsured and income <200% FPL? Go to a Title X clinic first. Screen for state Medicaid waiver eligibility at the same visit.
5. Uninsured and income 200-400% FPL? Apply to Bayer PAP and simultaneously contact the clinic about a payment plan for the insertion visit (device cost is the bigger barrier).
6. Undocumented or ineligible for Medicaid? Title X clinics serve patients regardless of citizenship status. Many Federally Qualified Health Centers (FQHCs) also operate on sliding-scale fees independently of Title X.

Private Insurance: Getting Coverage You May Already Have

A majority of women with employer-sponsored or marketplace insurance have IUD coverage they may not realize is fully in effect.

How to Verify Your Coverage Before the Appointment

Call the member services number on your insurance card and ask these specific questions:

• "Is a levonorgestrel IUD covered as a preventive contraceptive service with zero cost sharing?"
• "Is the insertion procedure covered separately from the device?"
• "Do I need prior authorization for this IUD?"
• "Is [specific clinic or provider name] in-network for this service?"

Get the name of the representative and a reference number for the call. If you are told coverage does not apply, ask for a denial in writing, then appeal citing the ACA Women's Preventive Services Guidelines, which explicitly list all FDA-approved contraceptive methods.

High-Deductible Health Plans (HDHPs)

Women on HDHPs before meeting their deductible often discover the IUD is not covered at $0 despite the ACA mandate. This happens because HDHPs with a Health Savings Account (HSA) have different rules around preventive care. The IRS ruled in 2020 that preventive services, including contraception, must be covered before the deductible under ACA-compliant plans. If your HDHP is ACA-compliant and denies contraceptive coverage until you meet your deductible, that may be an improper denial worth appealing or filing a complaint about through Healthcare.gov.

Grandfathered and Excepted Benefit Plans

Plans that existed before March 23, 2010 and have not made significant changes are exempt from the ACA contraceptive mandate. If you are on a grandfathered plan, you may have no ACA-based right to no-cost IUD coverage. Check with your HR department. In this case, Bayer PAP and Title X clinics become your most direct routes.

State-Funded Family Planning Programs

Beyond Medicaid and Title X, approximately 30 states operate their own state-funded family planning programs with separate funding streams and sometimes higher income thresholds. A 2023 Guttmacher Institute analysis found that state programs fill meaningful access gaps left by federal funding fluctuations.

Examples include California's Family PACT program (covers residents up to 200% FPL who do not have other coverage for family planning), New York's Medicaid family planning benefit, and Texas's Healthy Texas Women program. Each has distinct income thresholds, service bundles, and provider networks.

The simplest way to find your state's program: call a Title X clinic in your area. Their staff manage these programs daily and can screen you faster than any government website.

Who This Is Right For (and Who Should Think Twice)

A hormonal IUD is not the right fit for every woman, regardless of cost. Understanding where you are in your reproductive life affects whether Mirena or Kyleena makes sense clinically.

Reproductive Years (Ages 18 to 40)

Both devices are well-suited for women in their primary reproductive years. ACOG recommends LARC methods as first-line options for most women seeking highly effective contraception, including adolescents and nulliparous women. The hormonal IUD does not affect future fertility; ovulation typically returns within one to three months of removal.

Women with PCOS often benefit particularly from the LNG-IUS because it reduces endometrial hyperplasia risk associated with anovulatory cycles. Women with endometriosis or adenomyosis may see meaningful reduction in dysmenorrhea and bleeding with Mirena specifically, a finding supported by a Cochrane review of LNG-IUS for endometriosis-associated pain.

Perimenopause

Women in perimenopause (typically mid-40s to early 50s) have a specific reason to consider the LNG-IUS: it provides contraception during a period when fertility is declining but not zero, while also managing irregular and heavy bleeding that is common in this life stage. Mirena is FDA-approved for heavy menstrual bleeding, a condition that affects up to 25% of women in perimenopause. Women using the LNG-IUS who also need systemic estrogen for vasomotor symptoms can use the IUS as the progestogen component of a hormone therapy regimen, though this is an off-label use that requires discussion with your provider.

Not Right For: Active Pregnancy, Unexplained Uterine Bleeding, Certain Anatomical Conditions

The hormonal IUD is contraindicated in confirmed or suspected pregnancy. Women with unexplained abnormal uterine bleeding, distorted uterine cavity (fibroids that alter the cavity), current pelvic inflammatory disease, or certain cervical or uterine cancers are not candidates. Review your complete medical history with your provider before pursuing any access program.

Pregnancy, Lactation, and Contraception Requirements

Pregnancy: The hormonal IUD must not be placed in a pregnant woman. If pregnancy occurs with an IUD in place, the device should be removed as early as possible because in-situ IUDs during pregnancy carry risks of miscarriage, preterm birth, and sepsis. The FDA prescribing information for Mirena states explicitly that intrauterine pregnancy with a Mirena in place requires removal, with counseling about the risks of continuing the pregnancy.

Levonorgestrel IUDs are not teratogenic in the conventional sense, but they are not appropriate to use as treatment after pregnancy is confirmed.

Lactation: The LNG-IUS is considered compatible with breastfeeding. The American Academy of Pediatrics and ACOG both support postpartum IUD placement in breastfeeding women. Levonorgestrel does transfer minimally into breast milk, but the amounts are not considered clinically significant for the infant. No adverse effects on infant growth or development have been demonstrated in studies of up to 5 years.

Postpartum placement (immediately after delivery or at the 6-week visit) is often the most cost-efficient moment to obtain an IUD. Medicaid covers immediate postpartum placement in most states when billed correctly, and the insertion avoids a separate office visit later.

Contraception Requirements: No additional contraception is required once the IUD is correctly placed, with the exception of the first 7 days after insertion if you are not on your period at the time of placement. The IUD itself is the contraceptive method.

The Real Cost Over Time

Women sometimes focus on the $1,000 sticker price without calculating the per-year cost. Mirena costs roughly $125 per year if used for its full 8-year approved duration. Generic oral contraceptives cost $20 to $50 per month at cash pay, totaling $240 to $600 per year. The IUD is cheaper per year than the pill for most women who use it for more than two to three years, even without insurance.

A 2015 analysis published in AJOG found that the LNG-IUS was cost-effective compared to oral contraceptives within 2 years of use, even when device costs were not subsidized. This cost-effectiveness calculation shifts further in the IUD's favor when assistance programs bring the device cost to $0.

What to Bring to Your Appointment

Whichever pathway you use, come prepared with:

• Photo ID (Title X clinics do not require it for services, but it helps with paperwork)
• Proof of income (last two pay stubs, a tax return, or a self-attestation form if you have no formal income)
• Insurance card, if you have one, even if you think it will not cover the IUD
• Any documentation of a qualifying condition such as heavy menstrual bleeding, PCOS, or endometriosis (helps with dual-indication billing)
• A list of current medications (certain drugs interact with LNG, though systemic absorption from an IUD is low)

If a clinic tells you they cannot help you access an IUD affordably, ask them to refer you to their Title X-funded counterpart or a nearby FQHC before you leave.